- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 22, 2026 | 247.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 250.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 263.74M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $40.73M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $11.07M |
| Capex | Q1 2026 · Mar 31, 2026 | $10.67M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $5.77M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$26.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$60.01M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.44B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.33B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $114.94M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $104.54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $704.91M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $758.39M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.47B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.48B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.5B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.41B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.22B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.16B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.24B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.21B |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $190.64M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $179.36M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$12.97M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.92M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $9.64M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $18.29M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $459.53M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $412.09M |
| Revenue | Q1 2026 · Mar 31, 2026 | $704.14M |
| Revenue | Q1 2026 · Mar 31, 2025 | $651.74M |